Insurers point to what they believe to be a paucity of solid evidence that the bevy of tests are useful for making treatment decisions. Also, if they wait a few years, then it's Medicare's problem. Meanwhile, men with prostate cancer must pay about $3,000 out of pocket for genetic tests.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.